Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Empagliflozin> ?p ?o. }
Showing items 1 to 41 of
41
with 100 items per page.
- Empagliflozin abstract "Empagliflozin is drug which is being investigated in clinical trials for the oral treatment of type 2 diabetes by Boehringer Ingelheim and Eli Lilly and Company. It is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in the proximal tubules of nephronic components in the kidneys. SGLT-2 accounts for about 90 percent of glucose reabsorption into the blood. Blocking SGLT-2 causes blood glucose to be eliminated through the urine via the urethra.".
- Empagliflozin atcPrefix "A10".
- Empagliflozin atcSuffix "BX12".
- Empagliflozin casNumber "864070-44-0".
- Empagliflozin fdaUniiCode "HDC1R2M35U".
- Empagliflozin iupacName "(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol".
- Empagliflozin pubchem "11949646".
- Empagliflozin thumbnail Empagliflozin.svg?width=300.
- Empagliflozin wikiPageID "37113247".
- Empagliflozin wikiPageRevisionID "603179159".
- Empagliflozin atcPrefix "A10".
- Empagliflozin atcSuffix "BX12".
- Empagliflozin c "23".
- Empagliflozin casNumber "864070".
- Empagliflozin cl "1".
- Empagliflozin drugName "Empagliflozin".
- Empagliflozin h "27".
- Empagliflozin hasPhotoCollection Empagliflozin.
- Empagliflozin iupacName "-2".
- Empagliflozin legalStatus "Investigational".
- Empagliflozin molecularWeight "450.91".
- Empagliflozin o "7".
- Empagliflozin pubchem "11949646".
- Empagliflozin smiles "C1COC[C@H]1OC2=CC=CCC3=CCl".
- Empagliflozin stdinchi "1".
- Empagliflozin stdinchikey "OBWASQILIWPZMG-QZMOQZSNSA-N".
- Empagliflozin unii "HDC1R2M35U".
- Empagliflozin width "300".
- Empagliflozin subject Category:Glycosides.
- Empagliflozin subject Category:SGLT2_inhibitors.
- Empagliflozin type Drug.
- Empagliflozin type FunctionalSubstance.
- Empagliflozin comment "Empagliflozin is drug which is being investigated in clinical trials for the oral treatment of type 2 diabetes by Boehringer Ingelheim and Eli Lilly and Company. It is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in the proximal tubules of nephronic components in the kidneys. SGLT-2 accounts for about 90 percent of glucose reabsorption into the blood. Blocking SGLT-2 causes blood glucose to be eliminated through the urine via the urethra.".
- Empagliflozin label "Empagliflozin".
- Empagliflozin sameAs m.0n49z1d.
- Empagliflozin sameAs Q5373824.
- Empagliflozin sameAs Q5373824.
- Empagliflozin wasDerivedFrom Empagliflozin?oldid=603179159.
- Empagliflozin depiction Empagliflozin.svg.
- Empagliflozin isPrimaryTopicOf Empagliflozin.
- Empagliflozin name "Empagliflozin".